Latest Issues

Search TWST Online

Search by ticker:
or Sector:
Search by keyword:

Subscribe to TWST

The Wall Stree Transcript is a completely unique resource for investors and business researchers. Thousands of in-depth interviews with CEOs, Industry Analysts and Professional Money Managers going back 10 years.

To obtain a copy of a TWST issue/report order online or call (212) 952-7433 .

SUBSCRIBE

Article Excerpt:

Company Interview Excerpt
KEVIN O'NEILL - PYNG MEDICAL CORPORATION (PYT:TSX)


Full article published: 5/29/2006


For Subscribers

Get this article online now!

Order just this article
TWST: We would like to begin with a brief historical sketch of Pyng and a picture of the things you are doing at the present time.
Mr. O'Neill: The company was originally founded back in 1986, but got its real start in 1998 when it finally commenced development of a medical device called the F.A.S.T. 1. This is an intraosseous device. Intraosseous is an alternative to intravenous access to provide life- saving fluids and drugs to humans. We commenced sales in 2000 and have been selling the original product, the F.A.S.T. 1, since then.

TWST: Would you describe the F.A.S.T. 1 product and tell us what its advantages are?
Mr. O'Neill: The F.A.S.T. 1, as I said, is an intraosseous device. Intraosseous is a technique of introducing fluids into the body via the bone marrow. Essentially, you penetrate through the bone with a needle into the marrow and introduce the fluids. Our device is unique in the fact that it uses the sternum. This is the bone at the top of your chest. It is a very thin bone, but below that is a mass of red marrow, very close to the venal system itself, so when you put fluids into that marrow space, they very quickly have access to the complete venal system, plus the fact that we are close to the heart. The drugs can take effect very quickly. Major features of the system are the fact that it uses the sternum bone as the point of entry. We have automatic depth control, so you do not over-penetrate the sternum bone to introduce the fluids. In the marketplace, it is unique in the respect that the U.S. Army has studied the F.A.S.T. 1 and competing devices, and has elected the F.A.S.T. 1 as the device of choice for use within the U.S. Army.

 

Tickers included in this excerpt:

 

TWST Newsletter
Fill out your e-mail address
to receive our newsletter!

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.